Short answer
FENNEC PHARMACEUTICALS INC. (FENC) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All five director nominees re-elected, preserving board continuity through the next annual meeting.
FENNEC PHARMACEUTICALS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All five director nominees re-elected, preserving board continuity through the next annual meeting
- Haskell & White LLP appointment approved with 26,091,716 votes, confirming auditor oversight
- Executive compensation approved with 19,326,750 votes, while annual say-on-pay frequency received 18,235,648 votes
- 2020 Equity Incentive Plan amendments approved after excluding 766,153 insider-held shares from votes for
- 2026 Equity Inducement Plan ratified with 18,626,207 votes, supporting future employee and executive equity awards
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FENNEC PHARMACEUTICALS INC. 8-K filings
Get the next FENC 8-K as it lands
Follow FENC for push alerts, or ask the research agent what this filing means.